| Previous 10 | Next 10 |
Ad
VERV Articles Verve Therapeutics Inc. - From 04/05/24
home / stock / verv / verv articles
Articles | Verve Therapeutics Inc. (NASDAQ:VERV)
-
On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite the stock’s p...
-
Pipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much came out of bigwigs apart from a few, shares of c...
-
On Wednesday, Cathie Wood’s Ark Invest made a significant move by purchasing additional shares of Pinterest Inc (NYSE:PINS). The PINS Trade A...
-
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday. The Dow traded down 1.07% to 39,142.53 wh...
-
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. Stryve Foods post...
-
Verve Therapeutics Inc (NASDAQ:VERV) announced an update from the Heart-1 Phase 1b trial of VERVE-101. VERVE-101 is being evaluated in pa...
-
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 1.05% to 39,152.47 ...
-
LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investi...
-
BOSTON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of ca...
Stock Information
Get VERV Alerts
News, Short Squeeze, Breakout and More Instantly...
Verve Therapeutics Inc. Company Name:
VERV Stock Symbol:
NASDAQ Market:
1.39% G/L:
$4.32 Last:
2,498,877 Volume:
$4.25 Open:
$4.32 Close:
Verve Therapeutics Inc. Website:
Ad
-
Aeva Technologies Inc. (AEVA) is expected to report $-0.59 for Q1 2025 Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil) (LND) is expected to report for Q3 2025 Omron Corporation ADR (OMRNY) is expected to report for Q4 2025 Sezzle Inc. (SEZL) is expected to report $0.3...
-
2025-05-13 18:48:09 ET Verve Therapeutics, Inc. (VERV) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 8.12%. The average open to low on the day of earnings was -4.40%. The average open ...
-
2025-05-13 18:43:09 ET Verve Therapeutics, Inc. (VERV) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in VERV stock price following earnings has averaged ±5.24% , with a median of 2.87%....